Skip to content
Z Zendikt
Editorial verdict · Who it’s wrong for

Who shouldn’t buy Delinea Platform?

A direct read on the buyers Delinea Platform is the wrong fit for — sourced from the same editorial team that ranked the full Privileged Access Management (PAM) category.

Worst for

Federal and defense buyers needing FedRAMP High and DoD IL5 coverage, or organizations needing CyberArk-tier session brokering depth at Fortune 500 scale.

For context: who it IS for

Mid-market and lower-enterprise buyers (200-5,000 employees) wanting cloud-first PAM at 30-50% lower TCO than CyberArk, with a credible DevOps secrets story.

Target size: 200-10,000 · Mid-market and lower-enterprise PAM buyers

Why we say this

Editorial pulled these weaknesses from Delinea Platform’s product card in our Top 10 Privileged Access Management (PAM) Software (2026):

  • ! Session brokering depth still trails CyberArk PSM
  • ! Pricing opaque despite mid-market positioning
  • ! TPG ownership implies a sale or recap on the 3-5 year horizon
  • ! Centrify-side product line still in consolidation; some legacy SKUs feel stranded
  • ! Federal certification footprint narrower than CyberArk or BeyondTrust

If Delinea Platform is wrong for you, consider these instead

Same Privileged Access Management (PAM) category, different best-fit buyer.

Related editorial

Last updated 2026-05-17. Editorial verdict based on the published Top 10 Privileged Access Management (PAM) Software (2026) ranking. Disagree? Tell us.